2. Signaling Pathways
  3. Epigenetics
    JAK/STAT Signaling
    Protein Tyrosine Kinase/RTK
    Stem Cell/Wnt
  4. JAK
  5. JAK Control

JAK Control

JAK Isoform Comparison

JAK Control (1):

Cat. No. Product Name Effect Purity
  • HY-160144S1
    (S)-Lomedeucitinib
    		Control 99.09%
    (S)-Lomedeucitinib ((S)-BMS-986322) is a S-enantiomer of Lomedeucitinib (HY-160144S). Lomedeucitinib is a tyrosine protein kinase (TYK2) inhibitor.